CCNU
Term · Oncology and biomedicine · MLC-T-ONC-001520
A drug used to treat brain tumors that have already been treated with surgery or radiation therapy and Hodgkin lymphoma that got worse after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. CCNU damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called Gleostine and lomustine.
| Identifier | MLC-T-ONC-001520 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Gleostine; lomustine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001520",
"term": "CCNU",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat brain tumors that have already been treated with surgery or radiation therapy and Hodgkin lymphoma that got worse after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. CCNU damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called Gleostine and lomustine.",
"expansions": [
"Gleostine",
"lomustine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ccnu/"
}
Record 4,362 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.